Marek Skarupski

Dr. Marek Skarupski

Pure and Applied Mathematics, Wrocław University of Science and Technology, Wrocław, Dolnośląskie, Poland
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in Energies
Verified
Journal Article
Open access
PDF file
Anna Maria PawlicaAnna Maria Pawlica
Anna Maria Pawlica
Łukasz M. MichalecŁukasz M. Michalec
Łukasz M. Michalec
MSMarek Skarupski
Marek Skarupski
Michał JasińskiMichał Jasiński
Michał Jasiński
Tomasz SikorskiTomasz Sikorski
Tomasz Sikorski
TRTomasz Rodziewicz
Tomasz Rodziewicz
Power quality (PQ) becomes a more and more pressing issue for the operation stability of power systems with renewable energy sources. An important aspect of PQ monitoring of distribution networks is to compare the PQ indicators in different operating conditions. This paper evaluates the impact of a microgrid implementation in a real distribution network on power quality indicators at the point of common coupling in an LV network. The study includes a classical assessment of the long-term PQ parameters according to the EN 50160 standard, such as nominal frequency deviations, voltage RMS variations, voltage fluctuations (represented by long-term flicker severity), voltage unbalance and total harmonic distortion. The PQ evaluation is extended in statistical assessment based on cluster analysis. The case study contains 5 weeks of power quality observation results obtained at the assessment point in two different working conditions of the distribution system: before and after implementing the microgrid. The study allows establishing general conclusions regarding a microgrid interconnection in order not to exceed power quality limits and considering the influence of photovoltaic generation on power quality parameters.

14 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PRPiotr Rola
Piotr Rola
ADAdrian Doroszko
Adrian Doroszko
Malgorzata TrochaMalgorzata Trocha
Malgorzata Trocha
KGKatarzyna Giniewicz
Katarzyna Giniewicz
KKKrzysztof Kujawa
Krzysztof Kujawa
KMKatarzyna Madziarska
Katarzyna Madziarska
Senility has been identified among the strongest risk predictors for unfavorable COVID-19-outcome. However, even in the elderly population, the clinical course of infection in individual patients remains unpredictable. Hence, there is an urgent need for developing a simple tool predicting adverse COVID-19-outcomes. We assumed that the C2HEST-score could predict unfavorable clinical outcomes in the elderly subjects with COVID-19-subjects. Methods: We retrospectively analyzed 1047 medical records of patients at age > 65 years, hospitalized at the medical university center due to COVID-19. Subsequently, patients were divided into three categories depending on their C2HEST-score result. Results: We noticed significant differences in the in-hospital and 3-month and 6-month mortality-which was the highest in high-risk-C2HEST-stratum reaching 35.7%, 54.4%, and 65.9%, respectively. The medium-risk-stratum mortalities reached 24.1% 43.4%, and 57.6% and for low-risk-stratum 14.4%, 25.8%, and 39.2% respectively. In the C2HEST-score model, a change from the low to the medium category increased the probability of death intensity approximately two-times. Subsequently, transfer from the low-risk to the high-risk-stratum raised all-cause-death-intensity 2.7-times. Analysis of the secondary outcomes revealed that the C2HEST-score has predictive value for acute kidney injury, acute heart failure, and cardiogenic shock. Conclusions: C2HEST-score analysis on admission to the hospital may predict the mortality, acute kidney injury, and acute heart failure in elderly subjects with COVID-19.

ASAgata Sebastian
Agata Sebastian
MMMarcin Madziarski
Marcin Madziarski
MMMarta Madej
Marta Madej
KPKrzysztof Proc
Krzysztof Proc
MSMałgorzata Szymala-Pędzik
Małgorzata Szymala-Pędzik
KMKatarzyna Madziarska
Katarzyna Madziarska
Background: The COVID-GRAM is a clinical risk rating score for predicting the prognosis of hospitalized COVID-19 infected patients. Aim: Our study aimed to evaluate the use of the COVID-GRAM score in patients with COVID-19 based on the data from the COronavirus in the LOwer Silesia (COLOS) registry. Material and methods: The study group (834 patients of Caucasian patients) was retrospectively divided into three arms according to the risk achieved on the COVID-GRAM score calculated at the time of hospital admission (between February 2020 and July 2021): low, medium, and high risk. The Omnibus chi-square test, Fisher test, and Welch ANOVA were used in the statistical analysis. Post-hoc analysis for continuous variables was performed using Tukey’s correction with the Games–Howell test. Additionally, the ROC analysis was performed over time using inverse probability of censorship (IPCW) estimation. The GRAM-COVID score was estimated from the time-dependent area under the curve (AUC). Results: Most patients (65%) had a low risk of complications on the COVID-GRAM scale. There were 113 patients in the high-risk group (13%). In the medium- and high-risk groups, comorbidities occurred statistically significantly more often, e.g., hypertension, diabetes, atrial fibrillation and flutter, heart failure, valvular disease, chronic kidney disease, and obstructive pulmonary disease (COPD), compared to low-risk tier subjects. These individuals were also patients with a higher incidence of neurological and cardiac complications in the past. Low saturation of oxygen values on admission, changes in C-reactive protein, leukocytosis, hyperglycemia, and procalcitonin level were associated with an increased risk of death during hospitalization. The troponin level was an independent mortality factor. A change from low to medium category reduced the overall survival probability by more than 8 times and from low to high by 25 times. The factor with the strongest impact on survival was the absence of other diseases. The medium-risk patient group was more likely to require dialysis during hospitalization. The need for antibiotics was more significant in the high-risk group on the GRAM score. Conclusion: The COVID-GRAM score corresponds well with total mortality. The factor with the strongest impact on survival was the absence of other diseases. The worst prognosis was for patients who were unconscious during admission. Patients with higher COVID-GRAM score were significantly less likely to return to full health during follow-up. There is a continuing need to develop reliable, easy-to-adopt tools for stratifying the course of SARS-CoV-2 infection.

7 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DGDamian Gajecki
Damian Gajecki
ADAdrian Doroszko
Adrian Doroszko
Malgorzata TrochaMalgorzata Trocha
Malgorzata Trocha
KGKatarzyna Giniewicz
Katarzyna Giniewicz
KKKrzysztof Kujawa
Krzysztof Kujawa
KMKatarzyna Madziarska
Katarzyna Madziarska
Background: Diabetes mellitus is among the most frequent comorbidities worsening COVID-19 outcome. Nevertheless, there are no data regarding the optimal risk stratification of patients with diabetes and COVID-19. Since individual C2HEST components reflect the comorbidities, we assumed that the score could predict COVID-19 outcomes. Material and Methods: A total of 2184 medical records of patients hospitalized for COVID-19 at the medical university center were analyzed, including 473 diabetic patients and 1666 patients without any glucose or metabolic abnormalities. The variables of patients’ baseline characteristics were retrieved to calculate the C2HEST score and subsequently the diabetic and non-diabetic subjects were assigned to the following categories: low-, medium- or high-risk. The measured outcomes included: in-hospital mortality; 3-month and 6-month all-cause mortality; non-fatal end of hospitalization (discharged home/sudden-deterioration/rehabilitation) and adverse in-hospital clinical events. Results: A total of 194 deaths (41%) were reported in the diabetic cohort, including 115 in-hospital deaths (24.3%). The 3-month and 6-month in-hospital mortality was highest in the high-risk C2HEST stratum. The C2HEST score revealed to be more sensitive in non-diabetic-group. The estimated six-month survival probability for high-risk subjects reached 0.4 in both cohorts whereas for the low-risk group, the six-month survival probability was 0.7 in the diabetic vs. 0.85 in the non-diabetic group—levels which were maintained during whole observation period. In both cohorts, receiver operating characteristics revealed that C2HEST predicts the following: cardiogenic shock; acute heart failure; myocardial injury; and in-hospital acute kidney injury. Conclusions: We demonstrated the usefulness and performance of the C2HEST score in predicting the adverse COVID-19 outcomes in hospitalized diabetic subjects.

23 April 2019 in Mathematical Methods of Operations Research
Verified
Journal Article
Open access
PDF file
MSMarek Skarupski
Marek Skarupski
In the classical full-information best choice problem a decision maker aims to select the best opportunity. His decision is based only on the exact values of the observed sequence. In this paper we consider two modifications of the above problem. We add a second player who can either propose additional information or block the observed object and demand an extortion. Our goal is to establish an optimal reward for the second player and the best moment to interrupt the decision process. The situation when the number of observations tends to reach infinity has been studied.

17 March 2022 in Viruses
Verified
Journal Article
Open access
PDF file
PRPiotr Rola
Piotr Rola
ADAdrian Doroszko
Adrian Doroszko
Malgorzata TrochaMalgorzata Trocha
Malgorzata Trocha
KGKatarzyna Giniewicz
Katarzyna Giniewicz
KKKrzysztof Kujawa
Krzysztof Kujawa
KMKatarzyna Madziarska
Katarzyna Madziarska
Background: Since the outbreak of the COVID-19 pandemic, a growing number of evidence suggests that COVID-19 presents sex-dependent differences in clinical course and outcomes. Nevertheless, there is still an unmet need to stratify the risk for poor outcome at the beginning of hospitalization. Since individual C2HEST components are similar COVID-19 mortality risk factors, we evaluated sex-related predictive value of the score. Material and Methods: A total of 2183 medical records of consecutive patients hospitalized due to confirmed SARS-CoV-2 infections were analyzed. Subjects were assigned to one of two of the study arms (male vs. female) and afterward allocated to different stratum based on the C2HEST score result. The measured outcomes included: in-hospital-mortality, three-month- and six-month-all-cause-mortality and in-hospital non-fatal adverse clinical events. Results: The C2HEST score predicted the mortality with better sensitivity in female population regarding the short- and mid-term. Among secondary outcomes, C2HEST-score revealed predictive value in both genders for pneumonia, myocardial injury, myocardial infarction, acute heart failure, cardiogenic shock, and acute kidney injury. Additionally in the male cohort, the C2HEST value predicted acute liver dysfunction and all-cause bleeding, whereas in the female arm-stroke/TIA and SIRS. Conclusion: In the present study, we demonstrated the better C2HEST-score predictive value for mortality in women and illustrated sex-dependent differences predicting non-fatal secondary outcomes.